Similar articles

• Therapeutic applications of allogeneic BMT: aplastic anemia and the leukemias.

  Oblon DJ, Weiner RS, Mackin PJ. Oblon DJ, et al. J Fla Med Assoc. 1984 May;71(5):329-35. J Fla Med Assoc. 1984. PMID: 6376696 Review. No abstract available.
• Marrow transplantation for leukemia and aplastic anemia: two controlled trials of a combination of methotrexate and cyclosporine v cyclosporine alone or methotrexate alone for prophylaxis of acute graft-v-host disease.

  Storb R, Deeg HJ, Whitehead J, Farewell V, Appelbaum FR, Beatty P, Bensinger W, Buckner CD, Clift RA, Doney K, et al. Storb R, et al. Transplant Proc. 1987 Feb;19(1 Pt 3):2608-13. Transplant Proc. 1987. PMID: 3547942 Clinical Trial. No abstract available.
• Bone marrow transplantation.

  Epstein RB, Slease RB. Epstein RB, et al. Surg Annu. 1985;17:23-39. Surg Annu. 1985. PMID: 3883542 Review. No abstract available.
• The influence of the microbial flora on incidence of graft-versus-host disease in human allogeneic bone marrow transplantation.

  Schmeiser T, Kurrle E, Arnold R, Heit W, Krieger D, Kubanek B, Heimpel H. Schmeiser T, et al. Prog Clin Biol Res. 1985;181:433-5. Prog Clin Biol Res. 1985. PMID: 3895247 No abstract available.
• Bone marrow transplantation.

  Ramsay NK. Ramsay NK. Trans Assoc Life Insur Med Dir Am. 1988;71:162-73. Trans Assoc Life Insur Med Dir Am. 1988. PMID: 3285567 No abstract available.